BRIEF published on 04/11/2024 at 07:50, 1 year 11 months ago Marinomed Biotech AG Announces Dual Market Expansion for Carragelose Products Carragelose Market Expansion Marinomed Biotech Nasal Spray Allergen-blocking
BRIEF published on 04/11/2024 at 07:50, 1 year 11 months ago Marinomed Biotech AG annonce une double expansion du marché pour les produits à base de carragelose Marinomed Biotech L'expansion Du Marché Carrragélose Spray Nasal Blocage Des Allergènes
PRESS RELEASE published on 04/11/2024 at 07:45, 1 year 11 months ago Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico Marinomed Biotech AG expands Carragelose product portfolio with new launches in Austria and Mexico, targeting new indications and key markets Mexico Marinomed Biotech AG Carragelose Allergen-blocking Austria
BRIEF published on 03/28/2024 at 07:50, 1 year 11 months ago Marinomed Biotech AG Secures Loan Repayment Deferral with European Investment Bank Marinomed Biotech AG European Investment Bank Loan Repayment Deferral Marinosolv Platform Carragelose Business Expansion
BRIEF published on 03/28/2024 at 07:50, 1 year 11 months ago Marinomed Biotech AG obtient un report de remboursement de son prêt auprès de la Banque européenne d'investissement Marinomed Biotech AG Banque Européenne D'investissement Report De Remboursement Du Prêt Plateforme Marinosolv Expansion Des Activités De Carragelose
PRESS RELEASE published on 03/28/2024 at 07:45, 1 year 11 months ago Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months Marinomed Biotech AG European Investment Bank Deferral Agreement Marinosolv Platform Venture Loan
BRIEF published on 03/26/2024 at 07:50, 1 year 11 months ago Marinomed Biotech AG Expands Carragelose Distribution in Gulf Region and Eastern Europe Carragelose Marinomed GAIA Healthcare VitaPlus Kft Pharmaceutical Distribution
BRIEF published on 03/26/2024 at 07:50, 1 year 11 months ago Marinomed Biotech AG étend la distribution de carragelose dans la région du Golfe et en Europe de l'Est VitaPlus Kft Marinomé Carrragélose GAIA Santé Distribution Pharmaceutique
PRESS RELEASE published on 03/26/2024 at 07:45, 1 year 11 months ago Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe Marinomed Biotech AG partners with GAIA Healthcare FZ LLC and VitaPlus Kft. to distribute Carragelose nasal sprays in Gulf region and Eastern Europe, expanding market reach Marinomed Biotech AG Carragelose Distribution Partnerships GAIA Healthcare FZ LLC VitaPlus Kft.
BRIEF published on 03/01/2024 at 07:50, 2 years ago Marinomed Biotech AG Announces New Head of Investor & Public Relations Investor Relations Corporate Announcement Marinomed Biotech Public Relations Lucia Ziegler
Published on 03/23/2026 at 21:18, 20 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 7 hours 33 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 7 hours 38 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 8 hours 33 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 9 hours 6 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 21:05, 33 minutes ago Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 33 minutes ago Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 38 minutes ago Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 43 minutes ago Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable
Published on 03/23/2026 at 19:08, 2 hours 30 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 2 hours 30 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 3 hours 1 minute ago ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 3 hours 53 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 3 hours 53 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde
